No Data
Estimating The Fair Value Of Agilent Technologies, Inc. (NYSE:A)
TD Cowen Maintains Agilent Technologies(A.US) With Buy Rating, Maintains Target Price $153
J.P. Morgan Maintains Agilent Technologies(A.US) With Buy Rating
Barclays Maintains Agilent Technologies(A.US) With Sell Rating, Maintains Target Price $125
(A) - Analyzing Agilent Technologies's Short Interest
Express News | Agilent Technologies To Acquire BIOVECTRA For $925M, Expanding End-To-End Biopharma Solutions For Accelerated Drug Discovery And Development